0001209191-20-025998.txt : 20200428
0001209191-20-025998.hdr.sgml : 20200428
20200428174253
ACCESSION NUMBER: 0001209191-20-025998
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200428
FILED AS OF DATE: 20200428
DATE AS OF CHANGE: 20200428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLUMN GROUP II, LP
CENTRAL INDEX KEY: 0001600420
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 20826367
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4158652050
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Column Group II GP, LP
CENTRAL INDEX KEY: 0001645333
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 20826368
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-865-2050
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOEDDEL DAVID V
CENTRAL INDEX KEY: 0001182464
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 20826369
MAIL ADDRESS:
STREET 1: C/O COLUMN GROUP LP
STREET 2: 1700 OWENS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001796280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471787157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 388-5600
MAIL ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-28
0
0001796280
Oric Pharmaceuticals, Inc.
ORIC
0001600420
COLUMN GROUP II, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO
CA
94158
0
0
1
0
0001645333
Column Group II GP, LP
1700 OWENS STREET
SUITE 500
SAN FRANCISCO
CA
94158
0
0
1
1
General Partner
0001182464
GOEDDEL DAVID V
1700 OWENS STREET
SUITE 500
SAN FRANCISCO
CA
94158
0
0
1
1
Managing Partner
Common Stock
2020-04-28
4
C
0
3500000
A
3575000
D
Common Stock
2020-04-28
4
C
0
625000
A
4200000
D
Common Stock
2020-04-28
4
C
0
416666
A
4616666
D
Common Stock
2020-04-28
4
C
0
151515
A
4768181
D
Series A Preferred Stock
2020-04-28
4
C
0
3500000
0.00
D
Common Stock
3500000
0
D
Series B Preferred Stock
2020-04-28
4
C
0
625000
0.00
D
Common Stock
625000
0
D
Series C Preferred Stock
2020-04-28
4
C
0
416666
0.00
D
Common Stock
416666
0
D
Series D Preferred Stock
2020-04-28
4
C
0
151515
0.00
D
Common Stock
151515
0
D
Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.
The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
/s/ Jennifer J. Carlson, Attorney-in-Fact
2020-04-28